Total planned funding: $321,470,058
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $79,514,610 |
| South Africa | $46,249,173 |
| Asia Regional Program | $35,475,616 |
| Mozambique | $31,554,135 |
| West Africa Region | $13,460,980 |
| Kenya | $12,400,128 |
| Vietnam | $11,570,057 |
| Zimbabwe | $9,054,888 |
| Zambia | $7,988,118 |
| Democratic Republic of the Congo | $7,780,260 |
| Dominican Republic | $7,751,779 |
| Burundi | $7,625,625 |
| enumerations.Philippines | $6,341,584 |
| Botswana | $5,976,354 |
| Tanzania | $5,822,881 |
| Ethiopia | $5,596,768 |
| Malawi | $4,388,600 |
| Lesotho | $3,642,229 |
| Papua New Guinea | $3,494,885 |
| Uganda | $3,477,378 |
| Eswatini | $2,760,500 |
| Côte d'Ivoire | $2,738,453 |
| Angola | $2,250,000 |
| Rwanda | $1,713,822 |
| Haiti | $827,217 |
| Western Hemisphere Region | $709,018 |
| India | $600,000 |
| Namibia | $450,000 |
| Indonesia | $255,000 |
| Ghana | $0 |
| Caribbean Region | $0 |
| South Sudan | $0 |
Organizational Types
| NGO | $321,470,058 |
Program Areas
| Care | $96,344,107 |
| Treatment | $93,731,963 |
| Prevention | $65,184,437 |
| Testing | $38,232,402 |
| Governance and Systems | $27,977,149 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $84,547,404 |
| HKID: Care: Orphans and Vulnerable Children | $48,419,242 |
| HVCT: Testing: HIV Testing and Counseling | $38,232,402 |
| HBHC: Care: Adult Care and Support | $36,674,243 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $29,965,369 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,462,771 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,190,700 |
| OHSS: Health Systems Strengthening | $9,998,737 |
| HVSI: Strategic Information | $9,243,896 |
| HLAB: Laboratory Infrastructure | $8,734,516 |
| HVTB: Care: TB/HIV | $6,031,178 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,735,771 |
| PDCS: Care: Pediatric Care and Support | $5,219,444 |
| HTXD: Treatment: ARV Drugs | $5,082,114 |
| PDTX: Treatment: Pediatric Treatment | $4,102,445 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,512,634 |
| HMIN: Biomedical Prevention: Injection Safety | $258,760 |
| HMBL: Biomedical Prevention: Blood Safety | $58,432 |